Literature DB >> 10553803

IGF-I and TGF-beta2 have a key role on regeneration of nitric oxide synthase (NOS)-containing nerves after cavernous neurotomy in rats.

G W Jung1, J Y Kwak, S Yoon, J H Yoon, T F Lue.   

Abstract

The molecular mechanism of nitric oxide synthase (NOS)-containing nerve regeneration is still unknown. It is believed that growth factors are involved in this phenomenon. We investigated the change of NOS containing nerve fibers and the mRNA expression of insulin like growth factor (IGF)-I, nerve growth factor (NGF), transforming growth factor (TGF)-alpha, TGF-beta1, TGF-beta2, TGF-beta3, vascular endothelial growth factor (VEGF), endothelial NOS (eNOS) and neuronal NOS (nNOS) on the penis after cavernous nerve neurotomy in rats. Male rats were divided into four groups: (1) sham operation (n = 14); (2) unilateral neurotomy of a 5 mm segment of the cavernous nerve (n = 21); (3) unilateral neurotomy with growth hormone (n = 14); and (4) bilateral neurotomy (n = 21). Electrostimulation of the intact cavernous nerve or pelvic ganglion were performed at one, three and six months. Nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase staining and immunohistochemistry were used to identify NOS in the penis. The gene expression for growth factors, eNOS and nNOS were investigated in corporal tissue by reverse transcriptase-polymerase chain reaction (RT-PCR). One month after neurotomy, both unilateral and bilateral neurotomy groups showed significant decreases in NOS-containing nerve fibers on the dorsal and intracavernosal nerves on the side of neurotomy. Significantly lower mRNA expression of nNOS, IGF-I and TGF-beta2, higher mRNA expression of eNOS and VEGF189 were shown in these groups. At three months, the number of NOS-containing nerve fibers in the unilateral neurotomy group increased only slightly, while the GH-treated group showed a significant increase. At six months, those in the intracavernosal nerve only increased in a significant amount (P < 0.0001), however mRNA expression of nNOS, IGF-I and TGF-beta2 showed a significant increase as early as at three months. After bilateral neurotomy, the NOS-positive nerve fibers in the dorsal and intracavernosal nerve were significantly decreased at one month and remained so at six months; no erectile response could be elicited by pelvic ganglion stimulation. In the unilateral neurotomy group at six months, more NOS-positive neurons in the pelvic ganglia were found on the intact side than on the side of the neurotomy (P < 0.003), indicating that the regeneration derived from pelvic ganglion neurons on the intact side. Furthermore, electrostimulation in the unilateral neurotomy group revealed a greater maximal intracavernosal pressure and a shorter latency period at six months than at one month (P < 0.014, P < 0.001, respectively). These data suggest that IGF-I and TGF-beta2 may play a key role in the regeneration of nNOS-containing nerve fibers in the dorsal and intracavernosal nerves, and eNOS increases temporarily in the intracavernous involving VEGF189 after unilateral cavernous nerve injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553803     DOI: 10.1038/sj.ijir.3900402

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  13 in total

Review 1.  Neurogenic erectile dysfunction.

Authors:  T F Lue
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

Review 2.  Emerging tools for erectile dysfunction: a role for regenerative medicine.

Authors:  Lukman Hakim; Frank Van der Aa; Trinity J Bivalacqua; Petter Hedlund; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2012-07-24       Impact factor: 14.432

Review 3.  Emerging gene and stem cell therapies for the treatment of erectile dysfunction.

Authors:  Ahmed Harraz; Alan W Shindel; Tom F Lue
Journal:  Nat Rev Urol       Date:  2010-02-16       Impact factor: 14.432

Review 4.  Gene therapy as future treatment of erectile dysfunction.

Authors:  Naoki Yoshimura; Ryuichi Kato; Michael B Chancellor; Joel B Nelson; Joseph C Glorioso
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

5.  The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats.

Authors:  Kavirach Tantiwongse; Thomas M Fandel; Guifang Wang; Benjamin N Breyer; Thomas J Walsh; Anthony J Bella; Tom F Lue
Journal:  BJU Int       Date:  2008-07-01       Impact factor: 5.588

6.  Differentially expressed microRNAs in the corpus cavernosum from a murine model with type 2 diabetes mellitus-associated erectile dysfunction.

Authors:  Feng Pan; Jinwei You; Yuan Liu; Xuefeng Qiu; Wen Yu; Jiehua Ma; Lianjun Pan; Aixia Zhang; Qipeng Zhang
Journal:  Mol Genet Genomics       Date:  2016-09-28       Impact factor: 3.291

7.  The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model.

Authors:  Xie-Gang Ding; Shi-Wen Li; Xin-Min Zheng; Li-Quan Hu; Wan-Li Hu; Yi Luo
Journal:  Asian J Androl       Date:  2009-01-19       Impact factor: 3.285

Review 8.  Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactions.

Authors:  Kerry L Hull; Steve Harvey
Journal:  Int J Endocrinol       Date:  2014-12-15       Impact factor: 3.257

9.  Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage.

Authors:  Leah A Garcia; Su M Hlaing; Richard A Gutierrez; Maria D Sanchez; Istvan Kovanecz; Jorge N Artaza; Monica G Ferrini
Journal:  Int J Mol Sci       Date:  2014-09-26       Impact factor: 5.923

Review 10.  Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?

Authors:  Thomas E Ichim; Timothy Warbington; Octav Cristea; Joseph L Chin; Amit N Patel
Journal:  J Transl Med       Date:  2013-06-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.